These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

895 related items for PubMed ID: 8199080

  • 1. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ, Huang SC, Chow SN, Hsieh CY, Hsu HC.
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [Abstract] [Full Text] [Related]

  • 2. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I, Vejerslev LO, Frøding L, Blaakær J, Maroun LL, Hansen ES, Grove A, Lund H, Havsteen H, Sunde L.
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [Abstract] [Full Text] [Related]

  • 3. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
    Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM.
    Lancet; 1990 May 05; 335(8697):1074-6. PubMed ID: 1970378
    [Abstract] [Full Text] [Related]

  • 4. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul 05; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 5. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr 05; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 6. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE, Hancock BW, Short D, Harvey RA, Fisher RA, Drew D, Sarwar N, Tidy JA, Winter MC, Chien P, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar 05; 234():117-119. PubMed ID: 30684876
    [Abstract] [Full Text] [Related]

  • 7. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 05; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 8. Successful resolution of persistent trophoblastic disease after partial mole with the EMA-CO regimen.
    Dgani R, Zalel Y, Biran H, Blickstein I, Caspi B, Weissman A, Shoham Z.
    Eur J Obstet Gynecol Reprod Biol; 1994 Mar 31; 54(1):77-9. PubMed ID: 7519153
    [Abstract] [Full Text] [Related]

  • 9. Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidiform mole: comparison between complete and partial mole.
    Matsui H, Iitsuka Y, Suzuka K, Seki K, Sekiya S.
    Hum Reprod; 2001 Jun 31; 16(6):1274-7. PubMed ID: 11387305
    [Abstract] [Full Text] [Related]

  • 10. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M, Kane-Gueye SM, Ndiaye-Gueye MD, Mbaye M, Diouf AA, Niang MM, Diallo M, Moreau JC.
    BJOG; 2014 Oct 31; 121(11):1415-9. PubMed ID: 24674295
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Oct 31; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 12. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P, Hajri T, Massardier J, Lotz JP, Devouassoux-Shisheboran M, Allias Montmayeur F, You B, Golfier F, Bolze PA.
    Am J Obstet Gynecol; 2021 Oct 31; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [Abstract] [Full Text] [Related]

  • 13. Gestational trophoblastic disease following the evacuation of partial hydatidiform mole: a review of 66 cases.
    Zalel Y, Dgani R.
    Eur J Obstet Gynecol Reprod Biol; 1997 Jan 31; 71(1):67-71. PubMed ID: 9031962
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report.
    Vejerslev LO, Larsen G, Jacobsen M.
    Eur J Obstet Gynecol Reprod Biol; 1991 Jun 05; 40(1):73-7. PubMed ID: 1649776
    [Abstract] [Full Text] [Related]

  • 17. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB, Hidayat YM, Winarno GNA, Nisa AS, Alkaff FF.
    Am J Case Rep; 2021 Jun 15; 22():e931156. PubMed ID: 34127641
    [Abstract] [Full Text] [Related]

  • 18. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct 15; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 19. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ.
    BJOG; 2016 Jul 15; 123(8):1330-5. PubMed ID: 26444183
    [Abstract] [Full Text] [Related]

  • 20. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
    Albright BB, Shorter JM, Mastroyannis SA, Ko EM, Schreiber CA, Sonalkar S.
    Obstet Gynecol; 2020 Jan 15; 135(1):12-23. PubMed ID: 31809433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.